Clinical Study

Thromboelastography to Monitor Clotting/Bleeding Complications in Patients Treated with the Molecular Adsorbent Recirculating System

Figure 1

Scheme of parameters obtained by thromboelastography: Given are the clotting time (CT), the time in seconds passing until initial clot formation (CFT), the time in seconds passing until a strength of the clot of 20 mm is reached, the maximal clot firmness (MCF), an arbitrary unit in mm which reflects the maximal clot strength representing the interaction of fibrin and platelets and the remaining relative clot firmness after 60 minutes (Lys 60; %), representing fibrinolysis. Time is presented on the -axis (horizontal; grid 600 seconds), clot strength on the -axis (vertical; grid 20, resp., 40 mm).
313854.fig.001